Risks with continuous subcutaneous insulin infusion can be serious.
Knight
G
G
D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015918:Infusion Pumps, Implantable; D007263:Infusions, Parenteral; D007328:Insulin / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D007328:Insulin